XtalPi
Xinyang GONG is currently the Director of Corporate Finance & Strategy Development at 晶泰科技. Prior to this, Xinyang was an Equity Research Analyst Associate at Blue lotus capital, focusing on TMT, hard & core technology sectors. Xinyang also held positions in equity research, investment banking, and portfolio management at various prestigious companies such as 国信证券 and Pt Hedge Fund. Xinyang holds a Master's degree in Finance from Tulane University and was a candidate for a BA in Accounting from Xi'an Jiaotong-Liverpool University.
This person is not in any offices
XtalPi
XtalPi is a pharmaceutical technology company that is reinventing the industry’s approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform. Through its tightly interwoven quantum mechanics, artificial intelligence, and high-performance cloud computing algorithms, the ID4 platform enables pharmaceutical companies to increase their efficiency, accuracy, and success rate at critical stages of drug R&D. By accelerating the pace of drug discovery and development, XtalPi aims to contribute to a healthier society worldwide.